Used primarily in the field of medicinal chemistry, this compound serves as a key intermediate in the synthesis of various pharmacologically active molecules. Its structure is particularly valuable in the development of tricyclic antidepressants, which target neurotransmitter systems to alleviate symptoms of depression and anxiety disorders. Additionally, it finds application in the research and development of antipsychotic drugs, where its dibenzoazepine core is modified to enhance binding affinity to specific receptors in the brain. The methoxy group attached to the structure further aids in optimizing the pharmacokinetic properties of the resulting compounds, improving their efficacy and stability. Beyond mental health treatments, it is also explored in the design of compounds for neurological conditions, such as epilepsy and chronic pain management.